Terumo traded at 4,508.00 this Friday August 12th, increasing 174.00 or 4.01 percent since the previous trading session. Looking back, over the last four weeks, Terumo gained 6.12 percent. Over the last 12 months, its price rose by 3.47 percent. Looking ahead, we forecast Terumo to be priced at 4,271.05 by the end of this quarter and at 3,853.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
M3 Inc 4,711.00 179.00 3.95% -34.19%
Kyowa Hakko Kirin 3,185.00 65.00 2.08% -7.95%
Takeda 3,798.00 16.00 0.42% 3.38%
Astellas Pharma 2,034.50 20.00 0.99% 13.75%
Sumitomo Dainippon 1,104.00 -3.00 -0.27% -41.89%
Shionogi 6,916.00 54.00 0.79% 5.81%
Chugai Pharma 3,861.00 77.00 2.03% -6.01%
Eisai 6,115.00 20.00 0.33% -33.38%
Terumo 4,508.00 174.00 4.01% 3.47%
Daiichi Sankyo 3,677.00 45.00 1.24% 60.11%
Otsuka Holdings 4,688.00 69.00 1.49% 0.04%
Olympus 2,898.00 146.00 5.31% 29.40%

Indexes Price Day Year
JP225 28534 712.46 2.56% 1.99%

TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.